Article
Identification of novel biomarkers in renal cell carcinoma
7 Jun 2025
Abstract excerpt
INTRODUCTION: Renal Cell Carcinoma (RCC) is a heterogeneous disease, with distinct clinical outcomes for each subtype. Even within subtypes, outcomes differ and there is a need for novel biomarkers enabling risk stratification or predicting response to targeted therapies. AREAS COVERED: Epigenetic alterations, particularly aberrant DNA methylation and microRNAs deregulation, are a biomarker source that might be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
